Agents for preventing and treating disorders involving modulation of the ryanodine receptors
AssigneeThe Trustees of Columbia University in the City of New York
InventorsAndrew Robert Marks, Donald W. Landry, Shixian Deng
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of Formula I and salts, hydrates, solvates, complexes, and prodrugs thereof. The present invention further provides methods for synthesizing compounds of Formula I. The invention additionally provides pharmaceutical compositions comprising the compounds of Formula I and methods of using the pharmaceutical compositions of Formula I to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells.
Claims20
A compound which is selected from the group consisting of formula I-g, I-h, I-k-1, I-l-1, or I-m-1:
- wherein
- (a) the compound of formula I-g or I-h is:
- wherein W is S or O;
- n is 0, 1, or 2;
- q is 0, 1, 2, 3, or 4;
- each R is located at position 6, 7, 8 or 9 on the benzothiazepine ring;
- each R is independently selected from the group consisting of halogen, —OH, —NH2, —NO2, —CN, —CF3, —OCF3, —N3, —SO3H, —S(═O)2alkyl, —S(═O)alkyl, —OS(═O)2CF3, acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)aryl, (hetero-)arylthio, and (hetero-)arylamino;
- wherein each acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)aryl, (hetero-)arylthio, and (hetero-)arylamino may be substituted or unsubstituted;
- R15 and R16 independently are selected from the group consisting of H, acyl, alkenyl, alkoxyl, OH, NH2, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- and optionally R15 and R16 together with the N to which they are bonded may form a heterocycle which may be substituted or unsubstituted;
- and
- R′ and R″ are independently selected from the group consisting of H, halogen, —OH, —NH2, —NO2, —CN, —CF3, —OCF3, —N3, —SO3H, —S(═O)2alkyl, —S(═O)alkyl, —OS(═O)2CF3, acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)arylthio, and (hetero-)arylamino;
- wherein each acyl, alkyl, alkoxyl, alkylamino, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, and (hetero-)arylthio may be substituted or unsubstituted;
- provided that
- when q is 0 and n is 0, then —C(═W)NR15R16 is not —C(═O)NH2, —C(═O)NHPh, —C(═S)NH-nButyl, or —C(═O)NHC(═O)CH2Cl;
- when q is 0, n is 0 or 2, then —C(═W)NR15R16 is not —C═ONHPh, —C═ONHCOCH2Cl, —C═ONH2, —C═ONH(n-Bu), —C═S(NHPh), —C═S(NHCOCH2Cl), —C═S(NH2), or —C═SNH(n-Bu);
- (b) the compound of formula I-k-1 is:
- wherein
- n is 0, 1, or 2;
- R18 is selected from the group consisting of —NR15R16, —C(═O)—NR15R16, —OR15, —C(═O)—OR15, alkyl, aryl, cycloalkyl and heterocyclyl, wherein each alkyl, aryl, cycloalkyl and heterocyclyl may be unsubstituted or substituted;
- R15 and R16 independently are selected from the group consisting of H, acyl, alkenyl, alkoxyl, OH, NH2, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- and optionally R15 and R16 together with the N to which they are bonded may form a heterocycle which may be substituted or unsubstituted;
- p is 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;
- R′ is selected from the group consisting of halogen, —OH, —NH2, —NO2, —CN, —CF3, —OCF3, —N3, —SO3H, —S(═O)2alkyl, —S(═O)alkyl, —OS(═O)2CF3, acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)arylthio, and (hetero-)arylamino;
- wherein each acyl, alkyl, alkoxyl, alkylamino, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, and (hetero-)arylthio may be substituted or unsubstituted;
- and
- R″ is H;
- provided that when n is 0, and R′ is OH or C1-C3 alkoxyl, then —(CH2)p—R18 is not —(CH2)3-4-benzylpiperidine;
- (c) the compound of formula I-l-1 is:
- wherein
- n is 0, 1, or 2;
- R6 is selected from the group consisting of —OR15, —NHNR15R16, —NHOH, —CH2X, acyl, alkenyl, alkyl, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkyl, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- R15 and R16 independently are selected from the group consisting of H, acyl, alkenyl, alkoxyl, OH, NH2, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- and optionally R15 and R16 together with the N to which they are bonded may form a heterocycle which may be substituted or unsubstituted;
- X is selected from the group consisting of halogen, —CN, —CO2R15, —C(═O)NR15R16, —NR15R16, —OR15, —SO2R7, and —P(═O)R8R9;
- R7 is selected from the group consisting of —OR15, —NR15R16, —NHNR15R16, —NHOH, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each alkyl, alkenyl, alkynyl, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- R8 and R9 independently are selected from the group consisting of OH, acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- and
- R′ and R″ are independently selected from the group consisting of H, halogen, —OH, —NH2, —NO2, —CN, —CF3, —OCF3, —N3, —SO3H, —S(═O)2alkyl, —S(═O)alkyl, —OS(═O)2CF3, acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)arylthio, and (hetero-)arylamino;
- wherein each acyl, alkyl, alkoxyl, alkylamino, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, and (hetero-) arylthio may be substituted or unsubstituted;
- or
- (d) the compound of formula I-m-1 is:
- wherein
- n is 0, 1, or 2;
- R8 and R9 independently are selected from the group consisting of OH, acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl;
- wherein each acyl, alkenyl, alkoxyl, alkyl, alkylamino, aryl, cycloalkyl, cycloalkylalkyl, heterocyclyl, and heterocyclylalkyl may be substituted or unsubstituted;
- R′ and R″ are independently selected from the group consisting of H, halogen, —OH, —NH2, —NO2, —CN, —CF3, —OCF3, —N3, —SO3H, —S(═O)2alkyl, —S(═O)alkyl, —OS(═O)2CF3, acyl, alkyl, alkoxyl, alkylamino, alkylthio, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, (hetero-)arylthio, and (hetero-) arylamino;
- wherein each acyl, alkyl, alkoxyl, alkylamino, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkenyl, alkynyl, and (hetero-) arylthio may be substituted or unsubstituted.
A compound selected from the group consisting of:
- and a salt thereof.
Dependencies are inferred from the claim text.